共 11 条
[5]
Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial Disease: A Phase II Randomized, Double-Blind, Controlled Study of Adenoviral Delivery of Vascular Endothelial Growth Factor 121 in Patients With Disabling Intermittent Claudication[J] . Sanjay Rajagopalan,Emile R. Mohler,Robert J. Lederman,Farrell O. Mendelsohn,Jorge F. Saucedo,Corey K. Goldman,John Blebea,Jennifer Macko,Paul D. Kessler,Henrik S. Rasmussen,Brian H. Annex. Circulation: Journal of the Ameri
[6]
Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial[J] . Robert J Lederman,Farrell O Mendelsohn,R David Anderson,Jorge F Saucedo,Alan N Tenaglia,James B Hermiller,William B Hillegass,Krishna Rocha-Singh,Thomas E Moon,MJ Whitehouse,Brian H Annex. The Lancet . 2002 (9323)
[8]
GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function[J] . Ivo R Buschmann,Imo E Hoefer,Niels van Royen,Eva Katzer,Ruediger Braun-Dulleaus,Matthias Heil,Sava Kostin,Christoph Bode,Wolfgang Schaper. Atherosclerosis . 2001 (2)
[10]
Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype[J] . James N. Topper,Michael A. Gimbrone Jr. Molecular Medicine Today . 1999 (1)